|
شناسنامه علمي اطلاعات عمومي مهدی حاتمی پور تاریخ تولد: 1/12/1360 محل تولد: مشهد دانشگاه: علوم پزشكي مشهد دانشكده: داروسازی گروه آموزشي: شیمی دارویی مدرك و درجه علمي: دکتری شیمی دارویی Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences Email: این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید سوابق پژوهــشي جدول شماره 1 -مقالات در نشریات معتبر داخلی و خارجی 1. Zarrinfar H, Behnam M, Hatamipour M, Sahebkar A. Antifungal Activities of Curcuminoids and Difluorinated Curcumin Against Clinical Dermatophyte Isolates. Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health. 2021;1308:101-7. 2. Radbakhsh S, Momtazi-Borojeni AA, Mahmoudi A, Sarborji MR, Hatamipour M, Moallem SA, et al. Investigation of the Effects of Difluorinated Curcumin on Glycemic Indices in Streptozotocin-Induced Diabetic Rats. Natural Products and Human Diseases: Springer, Cham; 2021. p. 131-41. 3. Hatamipour M, Jamialahmadi T, Ramezani M, Tabassi SAS, Simental-Mendía LE, Sarborji MR, et al. Protective Effects of Curcumin Phytosomes Against High-Fat Diet-Induced Atherosclerosis. Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health. 2021;1308:37-44. 4. Hatamipour M, Jaafari MR, Zangui M, Shakour N, Sahebkar A. Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2021;21(17):2379-84. 5. Hatamipour M, Hadizadeh F, Jaafari MR, Khashyarmanesh Z, Sathyapalan T, Sahebkar A. Anti-proliferative potential of fluorinated curcumin analogues: experimental and computational analysis and review of the literature. Current Medicinal Chemistry. 2021. 6. Gheybi F, Alavizadeh SH, Rezayat SM, Hatamipour M, Akhtari J, Majidi RF, et al. pH-Sensitive PEGylated Liposomal Silybin: Synthesis, In Vitro and In Vivo Anti-Tumor Evaluation. Journal of Pharmaceutical Sciences. 2021;110(12):3919-28. 7. Gheibihayat SM, Jaafari MR, Hatamipour M, Sahebkar A. Improvement of the pharmacokinetic characteristics of liposomal doxorubicin using CD47 biomimickry. Journal of Pharmacy and Pharmacology. 2021;73(2):169-77. 8. Farhadi F, Nayebzadeh N, Badiee A, Arabsalmani M, Hatamipour M, Iranshahi M. A validated 1H-NMR method for quantitative analysis of DOTAP lipid in nanoliposomes containing soluble Leishmania antigen. Journal of Pharmaceutical and Biomedical Analysis. 2021;194:113809. 9. Dolatabadi S, Karimi M, Nasirizadeh S, Hatamipour M, Golmohammadzadeh S, Jaafari MR. Preparation, characterization and in vivo pharmacokinetic evaluation of curcuminoids-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs). Journal of Drug Delivery Science and Technology. 2021;62:102352. 10. Yazdani M, Hatamipour M, Alani B, Nikzad H, Roshan NM, Verdi J, et al. Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy. Iranian Journal of Basic Medical Sciences. 2020;23(8):1065. 11. Yazdani M, Gholizadeh Z, Nikpoor AR, Hatamipour M, Alani B, Nikzad H, et al. Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma. Vaccine. 2020;38(35):5665-77. 12. Reiner Ž, Hatamipour M, Banach M, Pirro M, Al-Rasadi K, Jamialahmadi T, et al. Statins and the COVID-19 main protease: in silico evidence on direct interaction. Archives of Medical Science: AMS. 2020;16(3):490. 13. Nik ME, Malaekeh-Nikouei B, Amin M, Hatamipour M, Teymouri M, Sadeghnia HR, et al. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma (vol 9, 9527, 2019). SCIENTIFIC REPORTS. 2020;10(1). 14. Hayat SMG, Bianconi V, Pirro M, Jaafari MR, Hatamipour M, Sahebkar A. CD47: role in the immune system and application to cancer therapy. Cellular Oncology. 2020;43(1):19-30. 15. Hayat SM, Jaafari MR, Hatamipour M, Penson PE, Sahebkar A. Liposome circulation time is prolonged by CD47 coating. Protein and peptide letters. 2020;27(10):1029-37. 16. Hatamipour M, Jaafari MR, Momtazi-Borojeni AA, Ramezani M, Sahebkar A. Evaluation of the anti-tumor activity of niclosamide nanoliposomes against colon carcinoma. Current molecular pharmacology. 2020;13(3):245-50. 17. Gheibi Hayat SM, Jaafari MR, Hatamipour M, Jamialahmadi T, Sahebkar A. Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin. Expert Opinion on Drug Delivery. 2020;17(7):1049-58. 18. Zamani P, Navashenaq JG, Nikpoor AR, Hatamipour M, Oskuee RK, Badiee A, et al. MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer. Journal of Controlled Release. 2019;303:223-36. 19. Yousefi F, Arab FL, Jaafari MR, Rastin M, Tabasi N, Hatamipour M, et al. Immunoregulatory, proliferative and anti-oxidant effects of nanocurcuminoids on adipose-derived mesenchymal stem cells. EXCLI journal. 2019;18:405. 20. Sahebkar A, Hatamipour M, Tabatabaei SA. Trehalose administration attenuates atherosclerosis in rabbits fed a high‐fat diet. Journal of cellular biochemistry. 2019;120(6):9455-9. 21. Nik ME, Malaekeh-Nikouei B, Amin M, Hatamipour M, Teymouri M, Sadeghnia HR, et al. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma. Scientific reports. 2019;9(1):1-15. 22. Jaafari MR, Hatamipour M, Alavizadeh SH, Abbasi A, Saberi Z, Rafati S, et al. Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis. International journal for parasitology: drugs and drug resistance. 2019;11:156-65. 23. Hatamipour M, Sahebkar A, Alavizadeh SH, Dorri M, Jaafari MR. Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids. Iranian journal of basic medical sciences. 2019;22(3):282. 24. Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Sahebkar A. Demethoxycurcumin: A naturally occurring curcumin analogue for treating non‐cancerous diseases. Journal of cellular physiology. 2019;234(11):19320-30. 25. Hatamipour M, Jaafari MR, Momtazi-Borojeni AA, Ramezani M, Sahebkar A. Nanoliposomal encapsulation enhances in vivo anti-tumor activity of niclosamide against melanoma. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2019;19(13):1618-26. 26. Bahramizadeh M, Bahramizadeh M, Kiafar B, Jafarian AH, Nikpoor AR, Hatamipour M, et al. Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model. International journal of pharmaceutics. 2019;569:118623. 27. Ramezani M, Hatamipour M, Sahebkar A. Promising anti‐tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue. Journal of cellular physiology. 2018;233(2):880-7. 28. Krishna SM, Moxon JV, Jose RJ, Li J, Sahebkar A, Jaafari MR, et al. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet. Journal of cellular physiology. 2018;233(10):6951-64. 29. Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Ramezani M, Sahebkar A. Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties. Journal of cellular physiology. 2018;233(12):9247-60. 30. Hatamipour M, Johnston TP, Sahebkar A. One molecule, many targets and numerous effects: the pleiotropy of curcumin lies in its chemical structure. Current pharmaceutical design. 2018;24(19):2129-36. 31. Razazan A, Behravan J, Arab A, Barati N, Arabi L, Gholizadeh Z, et al. Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model. PloS one. 2017;12(10):e0185099. 32. Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al. Treatment of non‐alcoholic fatty liver disease with curcumin: A randomized placebo‐controlled trial. Phytotherapy Research. 2016;30(9):1540-8. 33. Sahebkar A, Badiee A, Hatamipour M, Ghayour-Mobarhan M, Jaafari MR. Apolipoprotein B-100-targeted negatively charged nanoliposomes for the treatment of dyslipidemia. Colloids and Surfaces B: Biointerfaces. 2015;129:71-8. 34. Mehrabi H, Hatami-Pour M. Facile, one-pot synthesis of new phenanthridine derivatives through 1, 4-dipolar cycloaddition of phenantridine, activated acetylenes, and aromatic aldehydes. Chinese Chemical Letters. 2014;25(11):1495-8. 35. Kazemi-Beydokhti A, Heris SZ, Jaafari MR, Nikoofal-Sahlabadi S, Tafaghodi M, Hatamipoor M. Microwave functionalized single-walled carbon nanotube as nanocarrier for the delivery of anticancer drug cisplatin: in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology. 2014;24(6):572-8. 36. ZENDEHBAD B, AKHTARI J, HATAMIPOUR M, ALIPOUR A, ABDOLAHPOUR N. THE ANTI-CANDIDA EFFECTS OF ETHANOLIC EXTRACTS OF BERBERIS VULGARIS ROOT AND ZATARIA MULTIFLORA BOISS IN VITRO AND THEIR COMPARISON WITH CLOTRIMAZOLE AND AMPHOTERICIN B. 2013. 37. Tayarani-Najaran Z, Mousavi SH, Tajfard F, Asili J, Soltani S, Hatamipour M, et al. Cytotoxic and apoptogenic properties of three isolated diterpenoids from Salvia chorassanica through bioassay-guided fractionation. Food and chemical toxicology. 2013;57:346-51. 38. nMehrabi H, Hatami-pour M. Synthesis of functionalized pyrido [1, 2-f] phenanthridines from phenanthridine, activated acetylenes, and arylidenemalononitriles. Synthetic Communications. 2013;43(4):611-8. طرحهاي پژوهشي
مهارتها و سوابق حرفه ایسوابق حرفه ای: انجام مطالعه هم ارزی دوکسوروبیسین در انسان توسط روش LC ms/ms اعتبار سنجی تعیین مقدار داروهای آمفوتریسین بورتیزومب و دوکسوروبیسین به کمک روش HPLC انجام مطالعه فارماکوکینتیک کورکومین در حیوان به کمک روش HPLC مهارتها LC ms/ms, HPLC, GC, FTIR تفسیر و آنالیز انواع گرافهای تک بعدی و دو بعدی NMR و گرافهای دیگر روشهای طیف سنجی Office, Illustrator, Photoshop, Mnova, Graphpad prism افتخاراتانتخاب مقاله Treatment of non‐alcoholic fatty liver disease with curcumin: A randomized placebo‐controlled trial به عنوان پژوهش برتر سال 97 از طرف فرهنگستان علوم پزشکی
|